Current status: 824 hESC lines, 3017 hiPSC lines, and 95 clinical studies, and 386 certificates
Monthly statistic from Feb 1, 2022
Posted on February 1, 2022
| total lines | 3841 |
| hESC lines | 824 |
| hiPSC lines | 3017 |
| derivation countries | 40 |
| projects | 217 |
| providers | 691 |
| clinical studies | 95 |
| subclones | 1450 |
| certificates | 386 |
| cell line certificates | 278 |
| project certificates | 108 |